LOMITAPIDE (Lojuxta®)

Clinical Indication

Homozygous familial hypercholesterolaemia

Comments

Requested for UHL as part of NHS England commissioning policy.

Date of classification

September 2018

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.